| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |